Cafepharma Today

June 22 2018 - More IPOs this week: Autolus and Establishment Labs
More IPOs this week: Autolus and Establishment Labs
FDA limits first-line bladder cancer label for Keytruda and Tecentriq
FDA approves first glucose monitoring system with fully implantable sensor
Sanofi’s Dupixent scores NICE recommendation
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

Our microbiome database currently has 73 conditions for which biome-based products are being developed, & more added regularly. Review products by company, conditions treated, stage of development. Free access w/a subscription to our premium newsletter.


Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

Current News

submit a press release
With an AstraZeneca cancer drug in one hand, $37M in the other, Shanghai’s Alpha Bio zooms into a PhII study
Endpoints
Wednesday, June 20, 2018 - 9:47am
tags:
China, Alpha Bio, AstraZeneca
GSK takes billion-dollar drug fight with Gilead to top AIDS meeting
Yahoo/Reuters
Wednesday, June 20, 2018 - 9:28am
tags:
GSK, Gilead Sciences, HIV, AIDS, Dolutegravir, lamivudine, Biktarvy
5 Experimental New Drugs That Could Be Worth $47 Billion
Motley Fool
Wednesday, June 20, 2018 - 9:26am
tags:
GSK2857916, GSK, brolucizumab, Novartis, aducanumab, Biogen, upadacatinib, AbbVie, VX-659 + tezacaftor + ivacaftor, Vertex Pharmaceuticals
Genedrive plc Receives Grant to Develop Test to Avoid Antibiotic-related Hearing Loss in Newborns
CP Wire
Wednesday, June 20, 2018 - 9:24am
tags:
genedrive, antibiotic-related hearing loss
OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine
CP Wire
Wednesday, June 20, 2018 - 9:18am
tags:
OncBioMune, ProscaVax, prostate cancer, vaccines, clinical trials
Why PTC Therapeutics Dropped 30.6% Today After Jumping 27.5% Yesterday
Motley Fool
Tuesday, June 19, 2018 - 10:42pm
tags:
PTC Therapeutics, risdiplam, Biogen, Ionis Pharmaceuticals, spinal muscular atrophy, Sarepta Therapeutics, Translarna, Emflaza
Abbott's choice: acquire more businesses now or pay later
Modern Healthcare
Tuesday, June 19, 2018 - 10:26pm
tags:
Abbott Labs, M&A, devices
Bipartisan group of senators asks FDA to examine drug shortages
The Hill
Tuesday, June 19, 2018 - 10:22pm
tags:
Senate, FDA, drug shortages
Myriad Genetics Wins FDA SPMA Nod for BRACAnalysis CDx
Yahoo/Zacks.com
Tuesday, June 19, 2018 - 10:19pm
tags:
Myriad Genetics, FDA, BRACAnalysis CDx, diagnostics, Pfizer, talazoparib
Demand For Gene Therapies To Prompt Surge In Pharma M&A
Forbes
Tuesday, June 19, 2018 - 10:11pm
tags:
gene therapy, M&A, Bluebird Bio, Sangamo Therapeutics
3 patients add $2.5B to Sarepta's value
Biopharma Dive
Tuesday, June 19, 2018 - 9:45pm
tags:
Sarepta Therapeutics, Duchenne Muscular Dystrophy
Universal flu vaccine biotech seeks Big Pharma partnership for phase 3 testing: CEO
Fierce Pharma
Tuesday, June 19, 2018 - 9:41pm
tags:
Imutex, FLU-v, vaccines, universal flu vaccine, flu vaccines

Pages

Latest CP Wire Articles

FDA Approves First Glucose Monitoring System with Fully Implantable Sensor
NANOBIOTIX Achieves Primary and Secondary Endpoints in Ph II/III Study in Soft Tissue Sarcoma with NBTXR3
The Latest Biotech IPO - $150 million
Machine Learning Platform that Predicts Sepsis Goes Live
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
Heron's HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
An Overview of 36 State Laws Passed This Year to Control Pharmaceutical Costs
Next-Gen Cancer Immunotherapy Company Banks $75 Million Oversubscribed Series B Round
Genedrive plc Receives Grant to Develop Test to Avoid Antibiotic-related Hearing Loss in Newborns
OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine

Latest Pharmagather Articles

Piecing Together the Pricing Puzzle: The Midterm Elections
pharmexec r&d
Can Realistic Training Devices Help Make a Blockbuster?
pharmexec technology
Connecting the 5 Spheres of People-Based Marketing
pharmexec marketing
Why a Data Health Check May Be the Best Medicine for Pharmaceutical Regulatory Compliance
pharmexec r&d
Why a Data Health Check May Be the Best Medicine for Pharmaceutical Regulatory Compliance
pharmexec technology
Pragmatic AI in Pharma
pharmexec technology
C-Suite Personality: Fit for Future?
pharmexec top feature
Alzheimer’s and Infectious Disease: For Real
In the Pipeline
Welcome to Right to Try
In the Pipeline
Pharma Jobs from Indeed

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Pharma and Device News from NASDAQ

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Flex Pharma, Inc. (FLKS) and Encourages Investors to Contact the Firm
Friday, June 22, 2018 - 8:05pm
Axiom Real-Time Metrics Exhibiting at DIA Global Annual Meeting in Boston
Friday, June 22, 2018 - 12:00pm
CytoDyn Announces Productive Pre-BLA Meeting with FDA for PRO 140 Combination Therapy
Friday, June 22, 2018 - 6:00am
S. Parikh Mars, CEO of Progressive Care Inc., Provides Updates and Insights into Recent Events in a New Audio Interview with SmallCapVoice.com
Thursday, June 21, 2018 - 11:43am
Onconova Therapeutics Announces Promotion for Steven M. Fruchtman, M.D.
Thursday, June 21, 2018 - 8:00am
Top-Five National Payer Issues Positive Coverage Decision for Myriad’s Prolaris® Test for Prostate Cancer
Thursday, June 21, 2018 - 7:05am
Savaria Declares its Monthly Dividend
Wednesday, June 20, 2018 - 4:00pm
Diamond Equity Research Initiates Coverage on Oragenics Inc. (NYSE:OGEN) with a Valuation of $3.50 Per Share
Wednesday, June 20, 2018 - 9:30am
NewLink Genetics Announces Updated Data for Indoximod Plus Radio-Immunotherapy in DIPG to be Presented at ISPNO 2018 Meeting
Wednesday, June 20, 2018 - 9:00am
CytoDyn Provides Update on Phase 2 Clinical Trial with PRO 140 in GvHD
Wednesday, June 20, 2018 - 6:00am

Breaking Healthcare News - powered by Seeking Alpha

Trupanion announces pricing of $60M public offering of common stock
Thursday, June 21, 2018 - 9:29am
Onconova Therapeutics promotes Steven M. Fruchtman to the role of President
Thursday, June 21, 2018 - 9:23am
Premarket analyst action - healthcare
Thursday, June 21, 2018 - 9:19am
Polarityte appoints Paul Mann as Chief Financial Officer
Thursday, June 21, 2018 - 9:17am
Trillium up 13% premarket
Thursday, June 21, 2018 - 9:10am
Accuray receives AERB approval for sale and supply of Radixact X9 system in India
Thursday, June 21, 2018 - 9:03am
Moleculin announces $2.3M registered direct offering; shares down 15% premarket
Thursday, June 21, 2018 - 8:56am
EC grants full approval for Amgen's Blincyto
Tuesday, June 19, 2018 - 9:23am
Caladrius Bio up 25% premarket on accelerated review status in U.S. for CD34+ cell therapy
Tuesday, June 19, 2018 - 9:08am
Sandoz Canada to enter medical cannabis arena
Tuesday, June 19, 2018 - 9:01am

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.